About uMed

uMed operates a research platform embedded across a global healthcare network, enabling researchers to access deeply characterized patient cohorts without traditional site-based constraints. The company addresses the reality that two thirds of studies face delays from slow enrollment and 70% of patients live too far from research sites. The ACCESS Research Platform provides real-time integrated data from consented cohorts matching specific study requirements. This infrastructure makes clinical trials accessible to populations typically excluded from research, generating credible evidence whilst reducing the cost and resource burden of setting up studies.